Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Marta Magdycz

1PUBLICATIONS

39CO-AUTHORS

Biologically active molecules

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Mar 20, 2023

Arginase 1/2 Inhibitor OATD-02: From Discovery to First-in-man Setup in Cancer Immunotherapy.

Bartlomiej Borek, Julita Nowicka, Anna Gzik

Pageof 1

Frequent Collaborators

1 joint publications

Bartlomiej Borek

1 joint publications

Julita Nowicka

1 joint publications

Anna Gzik

1 joint publications

Marek Dziegielewski

1 joint publications

Karol Jedrzejczak

1 joint publications

Joanna Brzezinska

1 joint publications

Marcin Grzybowski

1 joint publications

Paulina Stanczak

1 joint publications

Paulina Pomper

1 joint publications

Agnieszka Zagozdzon

Frequent Collaborators

1 joint publications

Bartlomiej Borek

1 joint publications

Julita Nowicka

1 joint publications

Anna Gzik

1 joint publications

Marek Dziegielewski

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos